Stockreport

TFF Pharmaceuticals Announces Update on Clinical Programs

TFF Pharmaceuticals, Inc.  (TFFP) 
PDF Company to Prioritize Clinical Development of Tacrolimus Inhalation Powder (TFF TAC) based on Positive Phase 2 Data, the Potential to Address a Significant Unmet Need in [Read more]